Shionogi Announces Corporate Reorganization and Personnel Reassignment

OSAKA, Japan, August 30, 2023 - Shionogi & Co., Ltd.  (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that Shionogi will implement the following corporate reorganization and personnel reassignment as of October 1, 2023.

1.     Corporate Reorganization (see attached organization chart)

    I. Healthcare Business Supervisory Unit: Establishment of the Sales Promotion Department and dissolution of the Specialty Product Office

To centralize the management of data obtained through the use of digital tools and strengthen activity analysis and effect verification, the Sales Promotion Department will be established by integrating the digital strategy planning function for the domestic business, which has been carried out by the Healthcare Business Support Office under the Corporate Supervisory Unit, into the Sales Promotion Office. Furthermore, the Specialty Product Office will be dissolved by consolidating the MRs dedicated to specialty area products into the Sales Promotion Department and transferring other marketing functions to the New Product Planning Department to formulate cross-sectoral sales and marketing strategies.

    II. R&D Supervisory Unit: Dissolution of the Investment Strategy Department

In addition to integrating the Investment Strategy Department into the Business Development Department, part of the function of making strategic investments outside the company will be split and transferred to the Business Administration Office under the Corporate Supervisory Unit to further enhance investment management.

2.     Personnel Reassignments (Effective; October 1, 2023)

For Further Information, Contact:

SHIONOGI Website Inquiry Form : https://www.shionogi.com/global/en/contact.html